Impaired fibrinolysis in the antiphospholipid syndrome

Current Rheumatology Reports

Volumn 12, Issue 1, 2010, Pages 53-57

  Krone, Katie A ^a   Allen, Kristi L ^b   McCrae, Keith R ^c  

^a CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c TAUSSIG CANCER INSTITUTE   (United States)

Author keywords

Antiphospholipid; Beta2 glycoprotein I; Fibrin; Fibrinolysis; Plasminogen

Indexed keywords

BETA2 GLYCOPROTEIN 1; LIPOCORTIN 2; LIPOCORTIN 5; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN C; TISSUE FACTOR PATHWAY INHIBITOR; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; COMPLEMENT ACTIVATION; FIBRINOLYSIS; HUMAN; NONHUMAN; PATHOGENESIS; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; RECURRENT ABORTION; REVIEW; SIGNAL TRANSDUCTION; THROMBOSIS; VEIN THROMBOSIS;

ANTIPHOSPHOLIPID SYNDROME; BETA 2-GLYCOPROTEIN I; FIBRINOLYSIS; HUMANS;

EID: 77249085573     PISSN: 15233774     EISSN: 15346307     Source Type: Journal    
DOI: 10.1007/s11926-009-0075-4     Document Type: Review

References (39)

1. C Eby 2009 Antiphospholipid syndrome review Clin Lab Med 29 305 319 10.1016/j.cll.2009.06.001 19665680
2. MA Ozturk IC Haznedaroǧlu M Turgut H Goker 2004 Current debates in antiphospholipid syndrome: the acquired antibody-mediated thrombophilia Clin Appl Thromb Hemost 10 89 126 10.1177/107602960401000201 1:CAS:528: DC%2BD2cXktl2qsbo%3D 15094931 (Pubitemid 38490079)
3. JT Brandt DA Triplett BA Alving I Scharrer 1995 Criteria for the diagnosis of lupus anticoagulants: an update Thromb Haemost 74 1185 1190 1:CAS:528:DyaK2MXptVyhs7Y%3D 8560433
4. M Galli G Borrelli EM Jacobsen, et al. 2007 Clinical significance of different antiphospholipid antibodies in the WAPS (warfarin in the antiphospholipid syndrome) Blood 110 1178 1183 10.1182/blood-2007-01-066043 1:CAS:528:DC%2BD2sXptFKmu7Y%3D 17440049 (Pubitemid 47281414)
5. R Forastiero M Martinuzzo G Pombo, et al. 2005 A prospective study of antibodies to B2 glycoprotein I and prothrombin, and risk of thrombosis J Thromb Haemost 3 1231 1238 10.1111/j.1538-7836.2005.01295.x 1:CAS:528: DC%2BD2MXms1aqsr4%3D 15946213 (Pubitemid 41725247)
6. N Bizzaro A Ghiradello S Zampieri, et al. 2007 Anti-prothrombin antibodies predict thrombosis in patients with systemic lupus erythematosus: a 15-year longitudinal study J Thromb Haemost 5 1158 1164 10.1111/j.1538-7836. 2007.02532.x 1:CAS:528:DC%2BD2sXntl2ksb8%3D 17388963 (Pubitemid 46902116)
7. SS Pierangeli PP Chen E Raschi, et al. 2008 Antiphospholipid antibodies and the antiphospholipid syndrome: pathogenic mechanisms Semin Thromb Hemost 34 236 250 10.1055/s-0028-1082267 1:CAS:528:DC%2BD1MXnvF2gur8%3D 18720303
8. E Zorio J Gilabert-Estellés F España, et al. 2008 Fibrinolysis: the key to new pathogenetic mechanisms Curr Med Chem 15 923 929 10.2174/092986708783955455 1:CAS:528:DC%2BD1cXnsVyitbo%3D 18473800 (Pubitemid 351736413)
9. FJ Castellino VA Ploplis 2005 Structure and function of the plasminogen/plasmin system Thromb Haemost 93 647 654 1:CAS:528: DC%2BD2MXjs1ersb0%3D 15841308
10. T Renne D Gailani 2007 The role of factor XII in hemostasis and thrombosis: clinical implications Expert Rev Cardiovasc Ther 5 733 741 10.1586/14779072.5.4.733 1:CAS:528:DC%2BD2sXnt1egurY%3D 17605651 (Pubitemid 47050183)
11. K Huber 2001 Plasminogen activator inhibitor type-1 (part one): basic mechanisms, regulation, and role for thromboembolic disease J Thromb Thrombolysis 11 183 193 10.1023/A:1011955018052 1:CAS:528:DC%2BD38XhvVKgtQ%3D%3D 11577256 (Pubitemid 33069415)
12. RL Medcalf SJ Stasinopoulos 2005 The undecided serpin. The ins and outs of plasminogen activator inhibitor type 2 FEBS J 272 4858 4867 10.1111/j.1742-4658.2005.04879.x 1:CAS:528:DC%2BD2MXhtV2gt7jM 16176260 (Pubitemid 41415110)
13. KA Hajjar 1991 The endothelial cell tissue plasminogen activator receptor J Biol Chem 266 21962 21970 1:CAS:528:DyaK3MXmtVCgsrs%3D 1657983
14. M Kwon TJ MacLeod Y Zhang, et al. 2005 S100A10, annexin A2, and annexin a2 heterotetramer as candidate plasminogen receptors Front Biosci 10 300 325 10.2741/1529 1:CAS:528:DC%2BD2MXis1Snsb4%3D 15574370
15. Q Ling M Febbraio B Deora, et al. 2004 Annexin II is a key regulator of fibrin homeostasis and neoangiogenesis J Clin Invest 113 38 48 1:CAS:528:DC%2BD2cXjsVGmtQ%3D%3D 14702107
16. H Ishii M Yoshida M Hiraoka, et al. 2001 Recombinant annexin II modulates impaired fibrinolytic activity in vitro and in rat carotid artery Circ Res 89 1240 1245 10.1161/hh2401.101066 1:CAS:528:DC%2BD3MXptFKlsbY%3D 11739291
17. R Takeuchi T Atsumi M Ieko, et al. 2002 Suppressed intrinsic fibrinolytic activity by monoclonal anti-beta-2 glycoprotein I autoantibodies: possible mechanism for thrombosis in patients with antiphospholipid syndrome Br J Haematol 119 781 788 10.1046/j.1365-2141.2002.03928.x 1:CAS:528:DC%2BD3sXpsFGq 12437660 (Pubitemid 35366224)
18. M Ieko K Ichicawa T Atsumi, et al. 2000 Effects of beta 2-glycoprotein I and monoclonal anticardiolipin antibodies on extrinsic fibrinolysis Semin Thromb Haemost 26 85 90 10.1055/s-2000-9808 1:CAS:528:DC%2BD3cXjsFSitL4%3D
19. M Jurado JA Páramo M Gutierrez-Pimentel E Rocha 1992 Fibrinolytic potential and antiphospholipid antibodies in systemic lupus erythematosus and other connective tissue disorders Thromb Haemost 68 516 520 1:STN:280: DyaK3s%2FovVamtg%3D%3D 1455397
20. PR Ames C Tommasino L Iannaccone, et al. 1996 Coagulation activation and fibrinolytic imbalance in subjects with idiopathic antiphospholipid antibodies-a crucial role for acquired free protein S deficiency Thromb Haemost 76 190 194 1:CAS:528:DyaK28Xlt12jtb8%3D 8865529
21. T Atsumi MA Khamashta C Andujar, et al. 1998 Elevated plasma lipoprotein (a) level and its association with impaired fibrinolysis in patients with antiphospholipid syndrome J Rheumatol 25 69 73 1:STN:280:DyaK1c7hslCjuw%3D%3D 9458205
22. XN Li HE Grenett RL Benza, et al. 1997 Genotype-specific transcriptional regulation of PAI-1 expression by hypertriglyceridemic VLDL and Lp(a) in cultured human endothelial cells Arterioscler Thromb Vasc Biol 17 3215 3223 1:CAS:528:DyaK1cXisV2msg%3D%3D 9409314
23. PP Chen CD Yang K Ede, et al. 2008 Some antiphospholipid antibodies bind to hemostasis and fibrinolysis proteases and promote thrombosis Lupus 17 916 921 10.1177/0961203308092805 1:CAS:528:DC%2BD1cXhtlKru7%2FJ 18827056 Although the major autoantigen of APS is considered to be β2GPI, this article demonstrates that some aPL are capable of binding to homologous domains of key proteases involved in hemostasis and fibrinolysis
24. CD Yang KK Hwang W Yan, et al. 2004 Identification of anti-plasmin antibodies in the antiphospholipid syndrome that inhibit degradation of fibrin J Immunol 172 5765 5773 1:CAS:528:DC%2BD2cXjt1CkurY%3D 15100323
25. CS Lu AA Horizon KK Hwang, et al. 2005 Identification of polyclonal and monoclonal antibodies against tissue plasminogen activator in the antiphospholipid syndrome Arthritis Rheum 52 4018 4027 10.1002/art.21485 1:CAS:528:DC%2BD28XjvF2gsw%3D%3D 16320350 (Pubitemid 41798242)
26. M Cugno M Cabibbe M Galli, et al. 2004 Antibodies to tissue-type plasminogen activator (t-PA) in patients with antiphospholipid syndrome: evidence of interaction between the antibodies and the catalytic domain of t-PA in 2 patients Blood 103 2121 2126 10.1182/blood-2003-07-2422 1:CAS:528:DC%2BD2cXitlequro%3D 14630788 (Pubitemid 38326228)
27. BC Lutters PG de Groot RH Derksen 2002 beta 2 Glycoprotein I-a key player in the antiphospholipid syndrome Isr Med Assoc J 4 958 962 1:CAS:528: DC%2BD38XpsVSrurs%3D 12455190
28. G Valesini C Alessandri 2005 New facet of antiphospholipid antibodies Ann N Y Acad Sci 1051 487 497 10.1196/annals.1361.089 1:CAS:528:DC%2BD2MXhtFaktLnO 16126989 (Pubitemid 41362777)
29. S D'Ippolito N Di Simone F Di Nicuolo, et al. 2007 Antiphospholipid antibodies: effects on trophoblast and endothelial cells Am J Reprod Immunol 58 150 158 10.1111/j.1600-0897.2007.00500.x 17631008 This article illustrates a possible mechanism of how aPL can cause pregnancy complications and miscarriage in APS patients (Pubitemid 47097381)
30. MI Kamboh H Mehdi 1998 Genetics of apolipoprotein H (fl2-glycoprotein I) and anionic phospholipid binding Lupus 7 S10 S13 10.1177/096120339800700203 1:CAS:528:DyaK1cXntlSksbw%3D 9814664
31. DA Horbach E van Oort T Lisman, et al. 1999 Beta2-glycoprotein I is proteolytically cleaved in vivo upon activation of fibrinolysis Thromb Haemost 81 87 95 1:CAS:528:DyaK1MXhvVaqtLc%3D 10348717
32. S Yasuda T Atsumi M Ieko, et al. 2004 Nicked β2-glycoprotein I: a marker of cerebral infarct and a novel role in the negative feedback pathway of extrinsic fibrinolysis Blood 103 3766 3772 10.1182/blood-2003-08-2712 1:CAS:528:DC%2BD2cXjvF2iur0%3D 14726399 (Pubitemid 38596293)
33. F López-Lira L Rosales-León VM Martínez, et al. 2009 The role of beta2-glycoprotein I (beta2GPI) in the activation of plasminogen. Biochim Biophys Acta 2006, 1764:815-823.34.•• Bu C, Gao L, Xie W, et al.: beta2-glycoprotein i is a cofactor for tissue plasminogen activator-mediated plasminogen activation Arthritis Rheum 60 559 568 10.1002/art.24262
34. C Bu L Gao W Xie, et al. 2009 beta2-glycoprotein i is a cofactor for tissue plasminogen activator-mediated plasminogen activation Arthritis Rheum 60 559 568 10.1002/art.24262 1:CAS:528:DC%2BD1MXjt1Cnsrs%3D 19180513 This article presents a role for β2GPI in the regulation of fibrinolysis by showing that β2GPI interacts with tPA and induces tPA-dependent plasminogen activation in the fluid phase and that this process is inhibited by antibodies to β2GPI
35. I Lázaro F Carmona JC Reverter, et al. 2009 Antiphospholipid antibodies may impair factor XIIa-dependent activation of fibrinolysis in pregnancy: in vitro evidence with human endothelial cells in culture and monoclonal anticardiolipin antibodies Am J Obstet Gynecol 201 e1 e6 10.1016/j.ajog.2009.03.014 19427615
36. K Ma R Simantov JC Zhang, et al. 2000 High affinity binding of beta 2-glycoprotein I to human endothelial cells is mediated by annexin II J Biol Chem 275 15541 15548 10.1074/jbc.275.20.15541 1:CAS:528:DC%2BD3cXjsFamsbY%3D 10809787 (Pubitemid 30337288)
37. KA Hajjar AT Jacovina J Chacko 1994 An endothelial cell receptor for plasminogen/tissue plasminogen activator. I. Identity with annexin II J Biol Chem 269 21191 21197 1:CAS:528:DyaK2cXlslWqs7s%3D 8063740
38. GM Cesarman CA Guevara KA Hajjar 1994 An endothelial cell receptor for plasminogen/tissue plasminogen activator (t-PA). II. Annexin II-mediated enhancement of t-PA-dependent plasminogen activation J Biol Chem 269 21198 21203 1:CAS:528:DyaK2cXlsFCisro%3D 8063741
39. G Cesarman-Maus NP Ríos-Luna AB Deora, et al. 2006 Autoantibodies against the fibrinolytic receptor annexin 2, in antiphospholipid syndrome Blood 107 4375 4382 10.1182/blood-2005-07-2636 1:CAS:528:DC%2BD28Xlt1CgsLc%3D 16493010 (Pubitemid 43801363)